vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.
Mama's Creations, Inc. is the larger business by last-quarter revenue ($47.3M vs $31.1M, roughly 1.5× LIFECORE BIOMEDICAL, INC. \DE\). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -32.1%, a 33.3% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs -4.5%). Mama's Creations, Inc. produced more free cash flow last quarter ($3.7M vs $25.0K). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
LFCR vs MAMA — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $47.3M |
| Net Profit | $-10.0M | $540.0K |
| Gross Margin | 25.0% | 23.6% |
| Operating Margin | -9.9% | 1.7% |
| Net Margin | -32.1% | 1.1% |
| Revenue YoY | -4.5% | 50.0% |
| Net Profit YoY | -52.0% | 31.7% |
| EPS (diluted) | $-0.29 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.3M | ||
| Q3 25 | $31.1M | $35.2M | ||
| Q2 25 | — | $35.3M | ||
| Q1 25 | $35.2M | $33.6M | ||
| Q4 24 | $32.6M | $31.5M | ||
| Q3 24 | $24.7M | $28.4M | ||
| Q2 24 | — | $29.8M | ||
| Q1 24 | $35.7M | $26.7M |
| Q4 25 | — | $540.0K | ||
| Q3 25 | $-10.0M | $1.3M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | $-14.8M | $1.6M | ||
| Q4 24 | $-6.6M | $410.0K | ||
| Q3 24 | $-16.2M | $1.1M | ||
| Q2 24 | — | $553.0K | ||
| Q1 24 | $15.6M | $1.4M |
| Q4 25 | — | 23.6% | ||
| Q3 25 | 25.0% | 24.9% | ||
| Q2 25 | — | 26.1% | ||
| Q1 25 | 28.0% | 27.0% | ||
| Q4 24 | 34.0% | 22.6% | ||
| Q3 24 | 21.8% | 24.2% | ||
| Q2 24 | — | 25.0% | ||
| Q1 24 | 33.3% | 29.3% |
| Q4 25 | — | 1.7% | ||
| Q3 25 | -9.9% | 4.8% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | -25.7% | 5.7% | ||
| Q4 24 | -6.0% | 1.8% | ||
| Q3 24 | -46.9% | 5.7% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | -2.5% | 7.4% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | -32.1% | 3.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | -42.0% | 4.8% | ||
| Q4 24 | -20.2% | 1.3% | ||
| Q3 24 | -65.7% | 4.0% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | 43.8% | 5.3% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.29 | $0.03 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | $-0.47 | $0.04 | ||
| Q4 24 | $-0.25 | $0.01 | ||
| Q3 24 | $-0.53 | $0.03 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | $0.42 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $18.1M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $49.6M |
| Total Assets | $235.2M | $84.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $18.1M | ||
| Q3 25 | $18.9M | $9.4M | ||
| Q2 25 | — | $12.0M | ||
| Q1 25 | $5.4M | $7.2M | ||
| Q4 24 | $9.5M | $9.3M | ||
| Q3 24 | — | $7.4M | ||
| Q2 24 | — | $13.0M | ||
| Q1 24 | — | $11.0M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $49.6M | ||
| Q3 25 | $-10.5M | $29.6M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | $2.2M | $24.9M | ||
| Q4 24 | $15.4M | $23.0M | ||
| Q3 24 | $-3.9M | $22.3M | ||
| Q2 24 | — | $20.3M | ||
| Q1 24 | $17.7M | $19.6M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | $235.2M | $51.2M | ||
| Q2 25 | — | $52.7M | ||
| Q1 25 | $237.7M | $47.1M | ||
| Q4 24 | $255.4M | $47.9M | ||
| Q3 24 | $246.8M | $43.0M | ||
| Q2 24 | — | $47.2M | ||
| Q1 24 | $246.2M | $45.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $3.9M |
| Free Cash FlowOCF − Capex | $25.0K | $3.7M |
| FCF MarginFCF / Revenue | 0.1% | 7.8% |
| Capex IntensityCapex / Revenue | 5.6% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 7.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $6.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.9M | ||
| Q3 25 | $1.8M | $-1.7M | ||
| Q2 25 | — | $6.0M | ||
| Q1 25 | $1.2M | $-857.0K | ||
| Q4 24 | $-6.1M | $4.8M | ||
| Q3 24 | $-613.0K | $-2.4M | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | $-1.4M | $6.7M |
| Q4 25 | — | $3.7M | ||
| Q3 25 | $25.0K | $-2.2M | ||
| Q2 25 | — | $5.5M | ||
| Q1 25 | $-4.3M | $-930.0K | ||
| Q4 24 | $-8.6M | $2.5M | ||
| Q3 24 | $-4.0M | $-4.0M | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | $-7.8M | $6.6M |
| Q4 25 | — | 7.8% | ||
| Q3 25 | 0.1% | -6.2% | ||
| Q2 25 | — | 15.5% | ||
| Q1 25 | -12.1% | -2.8% | ||
| Q4 24 | -26.3% | 8.0% | ||
| Q3 24 | -16.3% | -14.1% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | -21.8% | 24.8% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 5.6% | 1.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | 15.5% | 0.2% | ||
| Q4 24 | 7.5% | 7.2% | ||
| Q3 24 | 13.9% | 5.6% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | 17.8% | 0.4% |
| Q4 25 | — | 7.16× | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | 4.85× | ||
| Q1 25 | — | -0.54× | ||
| Q4 24 | — | 11.71× | ||
| Q3 24 | — | -2.10× | ||
| Q2 24 | — | 6.58× | ||
| Q1 24 | -0.09× | 4.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
MAMA
Segment breakdown not available.
